Trial intelligence / Profile preview

Avanti: GnRH Agonist vs Antagonist for PGD

NCT01888744Phase 4Completed

Sponsor
UZ Brussel
Start
Sep 2010
Primary completion
Jun 2013
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ganirelix, cetrorelix, triptorelin, buserelin in female infertility, sponsored by UZ Brussel. Started Sep 2010; status: completed.

02

Drugs

ganirelixcetrorelixtriptorelinbuserelin
03

Conditions

female infertility

Beyond the preview

Go deeper on NCT01888744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01888744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call